Business
Notice of Interim Results and Investor Webinar
Notice of Interim Results and Investor Webinar.
About this update from Oxford Biodynamics Plc
[{"type":"text","content":"\n\nOxford BioDynamics Plc\n \nNotice of Interim Results and Investor Webinar\n \nOxford, UK - 16 May, 2023 - Oxford BioDynamics, Plc (AIM: OBD, OBD\" or the \"Company\" and, together with its subsidiaries, the \"Group\"), a biotechnology company developing precision medicine tests based on the EpiSwitch® 3D genomics platform, expects to announce its interim results for the half-year ended 31 March 2023 on Tuesday 30 May 2023.\n \nFollowing the release of the results, the Company's management team will conduct a live presentation to investors via the Yellowstone Advisory webinar platform. The online presentation is open to both existing and potential shareholders. Questions may be submitted both before and during the presentation by emailing [email protected].\n \nThe webinar will take place at 2pm BST on 30 May 2023. To register, please visit: https://us02web.zoom.us/webinar/register/3216841534960/WN_XzaMPjm_TE6YFtNcxVxC1g\n \n -Ends- \nFor further details please contact:\n\n\n\nOxford BioDynamics Plc\nJon Burrows, CEO\nPaul Stockdale, CFO\n \n\n\n+44 (0)1865 518910\n \n\n\n\n\nShore Capital\nNominated Adviser and Broker\nStephane Auton\nJohn More\n \n\n\n+44 (0)20 7408 4090\n \n\n\n\n\nInstinctif Partners\nMelanie Toyne-Sewell\nRozi Morris\nAdam Loudon\n\n\n \n +44 (0)20 7457 2020\[email protected]\n \n\n\n\n \nAbout Oxford BioDynamics Plc\nOxford BioDynamics Plc (AIM: OBD) is a global biotechnology company, advancing personalized healthcare by developing and commercializing precision medicine tes...